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ABSTRACT
Objective: The aim of this paper is to create a new, systematic high-performance thin-layer chromatography (HPTLC) method for ciprofloxacin that 
is based on quality by design (QbD).
Methods: The mobile phase was chloroform: IPA: H2O: Formic Acid (2:7:0.5:0.5V/V), and the chromatographic separation was performed on 
aluminum-backed silica gel 60 F254 plates. Ciprofloxacin was detected using UV light at 278nm. In factor screening studies, a 3-factor 17-run 
standard 3-level factorial design was used, and a Box-Behnken design was used to optimize HPTLC experimental parameters for obtaining anticipated 
chromatographic conditions. The basic method parameters were tested to understand risk assessment. Three independent parameters, such as 
saturation time, band duration, and migration distance, were chosen and analyzed based on the risk assessment to see if these three parameters 
influenced the responses. For ciprofloxacin, the method produces a compact and well-resolved band at Rf = 0.40 0.02. In the linear regression analysis 
performed on ciprofloxacin, the regression coefficient was found to be r2 = 0.996.
Results: According to the International Council on Harmonization (ICH) guidelines, it was validated for validation parameters such as accuracy, 
precision, robustness, the limit of detection, and the limit of quantification. The proposed method for ciprofloxacin determination was found to be 
straightforward, precise, reliable, stable, and sensitive.
Conclusion: The QbD method produced a more robust method that can generate accurate, high-quality, and reliable data during the process, and it 
can be effectively used in the routine inspection of Ciprofloxacin in the tablets dosage form.
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INTRODUCTION
Ciprofloxacin is a type of antibiotic. Ciprofloxacin is a carboxylic acid 
that is made up of 1-cyclopropyl-6-fluoro-4-oxo-7-piperazine-1-
ylquinoline-3-carboxylic acid. Bayer A.G. patented ciprofloxacin in 
1983, and it was first used in 1987 [1,2]. Ciprofloxacin is classified as an 
important medication by the World Health Organization. Ciprofloxacin 
is classified as essential for human medicine by the WHO. Ciprofloxacin 
was a generic drug that was available. With over 6 million prescriptions 
written in 2018, ciprofloxacin was the 109th most widely prescribed 
drug in the United States. The FDA has approved Ciprofloxacin for 
urinary tract infections, sexually transmitted infections, bone, and joint 
infections [3,4].
It’s a fluoroquinolone antibiotic with a wide range of action. 
Ciprofloxacin works against both gram-positive and gram-negative 
bacteria, inhibiting cell division by inhibiting a type II DNA gyrase 
and topoisomerase IV, which are needed to distinguish bacterial 
DNA. Ciprofloxacin can be taken orally or intravenously [5,6]. 
At therapeutic doses, ciprofloxacin’s side effects are minor and 
often consist of gastrointestinal disturbances including nausea 
and diarrhea [7]. Non-aqueous titration, UV spectrophotometry, 
colorimetry, high-performance liquid chromatography, HPLC with 
mass spectroscopy, thin-layer chromatography, gas chromatography, 
and other methods were used to evaluate it. Non-aqueous 
titration, UV spectrophotometry, colorimetry, high-performance 
liquid chromatography, HPLC with mass spectroscopy, thin-layer 
chromatography, gas chromatography, and capillary electrophoresis 
were all used to evaluate it [8,9].
In this study, Box-Behnken design was used for the optimization of 
chromatographic analysis of the HPTLC analysis. This design was 
decided due to its adaptability to change or include or cross out any 
parameter at any time when our work is ongoing. This work aimed to 
develop and validate a quality by a design-based efficient method using 
HPTLC (Fig. 1) [10].
METHODS
Chemical and reagents
Cipla LTD offered a free sample of Ciprofloxacin (Mumbai, India). 
HiMedica Laboratories PVT LTD was also purchased chloroform 
(ARGrade) from (India, Mumbai, LTD) E. Merck PVT LTD provided 
HPTLC plate silica gel 60 F254 (Mumbai India).
Instrumentation
Methanol was used to prewash HPTLC plates, which were then triggered 
in a 120°C oven for 10 minutes before chromatography. The production 
was carried out in a 20 cm × 10 cm twin through glass chamber with 
chloroform, isopropyl alcohol, water, and formic acid (2:7:0.5:0.5 v/v) as 
the mobile step and a development distance of 80 mm after 10 minutes 
of saturation with mobile vapor. The chromatography plates were dried 
with an air dryer after growth, and for the current analytical analysis, a 
CAMAG (Muttenz, Switzerland) HPTLC device with a CAMAG LINOMAT 
sample applicator, a Hamilton syringe (Bonduz, Switzerland), and a 
CAMAG TLC Scanner with WINCATS software was used.
Preparation of standard stock solution
The study was to make the stock solution, dissolve 5 mg in 10 ml 
methanol to obtain a concentration of 500l.
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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Selection of analytical wavelength
The bands were scanned over a range of 400-200 nm after 
chromatographic development, and a wavelength of 278 nm was 
reached, which was used to detect method development and validation.
Method development as per experimental design
The Ishikawa fishbone diagram was created using Microsoft Excel at 
the start of the risk assessment plan to structure the risk operation 
plan for the factors that influence the system [11,12]. Critical analytical 
attributes (CAAs) 17 were studied using a standard 3-factorial design to 
determine the critical system parameters/critical process parameters 
that primarily affect the CAAs (saturation time, band length, migration 
distance) [13,14]. Using the software suggested in Table 1, the design 
matrix enrolled considered factors and their low, medium, and high 
levels. The experimental design runs were analyzed for the influence of 
the study factors on the CAAs.
CMPs, particularly saturation time, band length, and migration distance, 
were studied at three levels, namely low, medium, and high, using the 
box-Behnken design. According to the Box-Behnken design, a design 
matrix consists of 17 experimental runs. The mathematical software 
Design-Expert version 11 was used to evaluate all of the findings.
RESULTS AND DISCUSSION
Optimization and data analysis
Design-expert software version 11 was used to optimize data analysis 
by choosing a quadratic model for detecting retardation factor. For 
CAAs (as given in Fig. 2), the 3D response surface plot was observed, as 
well as the product of the model’s analysis of variance (ANOVA) for the 
Rf value of the ciprofloxacin chromatogram. The model’s estimation of 
the Rf value was statistically important, as shown by a probability value 
of less than 0.05. For the Rf value responses, all quadratic terms were 
found to be meaningful.
With a saturation time of 10 minutes, a band length of 0.4mm, and a 
migration distance of 80 cm, the numerical optimization indicated 
optimal conditions (Table 2 and Figs. 2-4).
Method validation
According to the International Council of Harmonization (ICH) 
guidelines, the existing method was validated for linearity, accuracy 
(percent recovery), precision, robustness, the limit of detection (LOD), 
and the limit of quantification (LOQ).
Linearity
For ciprofloxacin, the typical calibration curve was plotted in a 
concentration range of 50–300 ng per band, respectively. The coefficient 
Table 1: Design matrix as per Box‑Behnken for optimization of 
the HPTLC method






1 10 4 70
2 5 8 80
3 15 8 80
4 5 6 70
5 15 6 90
6 15 6 70
7 10 6 80
8 5 6 90
9 15 4 80
10 10 6 80
11 10 6 80
12 5 4 80
13 10 8 70
14 10 6 80
15 10 4 90
16 10 6 80
17 10 8 90Fig. 1: Ciprofloxacin structure
Fig. 2: 3D response surface plots of Ciprofloxacin (a) showing of band length and saturation time on the rf value, (b) the influence of 
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values for the used linearity spectrum were strong (r2=0.996). For 
ciprofloxacin, the linear regression equations were found to be 
y=769.969x+533.278. The linearity calibration curves are shown in 
Fig. 5.
Precision
The %RSD values for ciprofloxacin intra-day were found to be 0.38, 
respectively. The % RSD values for ciprofloxacin inter-day were found 
to be 1.33, respectively (<2).
Robustness
The standard deviation of areas was calculated for each condition 
and %RSD was less than 2%. The result of robustness is shown in the 
following Table 3.
Accuracy
The experiment’s precision was determined by spotting a drug standard 
solution over the pre-analyzed sample solution. The recovery research 
was conducted at three different levels: 80%, 100%, and 120 percent. 
Table 4 displays the outcome.
Limit of detection and limit of quantification
The developed method’s LOD and LOQ for ciprofloxacin were found to 
be 24.98 and 75.69 ng per band, respectively, indicating the proposed 
method’s sensitivity. Table 5 displays the LOD and LOQ data.
Table 2: Results of analysis of ANOVA (ciprofloxacin)
Responses SS DF MS F‑value p‑value Results
Rf 0.0823 9 0.0091 22.67 0.0002 Significant
RF: Retention factor, SS: Sum of squares, DF: Degree of freedom, MS: Mean square
Table 3: Robustness study
Robustness %RSD
Mobile phase composition (±0.1 ml) 0.78
Saturation time (±5 min) 1.17
Development to scanning (±5 min) 0.99
Volume of the mobile phase (±1 ml) 0.28
Spotting to development (±5 min) 1.16
Fig. 4. Typical chromatogram of ciprofloxacin
Fig. 3: Overlaid spectra of ciprofloxacin
Fig. 6: Densitogram of alkali (0.1N NaOH) treated sample.
Fig. 5: Linearity of ciprofloxacin Fig. 7: Densitogram of the sample exposed to heat
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Stress degradation study
Significant degradation of ciprofloxacin was observed under neutral 
hydrolysis conditions. While lesser degradation was observed under 
alkaline hydrolysis and oxidative condition. 6.45% degradation was 
observed for ciprofloxacin in alkaline hydrolysis (3 ml in 0.1N NaOH) 
after keeping it at room temperature for ½ hrs. Ciprofloxacin showed 
oxidative degradation at room temperature for ½ h of about 6.96%. 
Ciprofloxacin showed degraded product peaks at Rf 0.41 and 0.89 under 
dry heat (oven 40°C 30 min). Ciprofloxacin was found to be degraded 
up to 7.28% with a decrease in an area only. Photolytic studies were 
also carried out by exposure of the drug to UV light for 24 h on 254 
(Table 6 and Figs. 6-11).










Amount of drug 
recovered
% Recovery
80 5 200 4 3.93 98.25
Ciprofloxacin 100 5 200 5 5.03 100.6
120 5 200 6 6.05 100.83
Table 6: Observation table
Conditions Degradation (%)
0.1N NaOH (room temp for ½ h) 6.45%
0.1 N HCL (room temp for ½ h) 8.39%
3% H2O2(room temp for ½ h) 6.96%
H2O (1/2 h) 9.43%
Dry heat 40°C for 30 min 7.28%
UV light for 24 h 254 nm 8.29%
Table 5: Summary of linear regression and validation data
Parameters Ciprofloxacin
Linearity range [ng per band] 50–300 ng per band




Limit of detection (ng per band) 24.98
Limit of Quantification (ng per band) 75.69
System precision (% RSD) 0.48
Intra-day (% RSD) 0.38
Inter-day (% RSD) 1.33
Fig. 10: Densitogram of the sample exposed to neutral hydrolysis
Fig. 11: Densitogram of oxide (3% H2O2) treated sample
Fig. 8: Densitogram of the sample exposed to UV radiations
Fig. 9: Densitogram of acid (0.1 N HCL) treated sample
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CONCLUSION
The box-Behnken design and response surface methodology are useful 
tools for determining the sensitivity of ciprofloxacin Rf values to various 
chromatographic variables. Using a useful experimental design method, 
the saturation period, band duration, and migration distance were all 
optimized at the same time. It is a cost-effective method for generating 
a large volume of data in a short amount of time with a limited number 
of experiments. The proposed method for ciprofloxacin determination 
was found to be straightforward, precise, reliable, stable, and sensitive. 
The QbD method produced a more robust method that can generate 
accurate, high-quality, and reliable data during the process.
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